Search Site
Home >> Research Area >> Metabolism

Metabolism

Metabolism is the set of life-sustaining chemical transformations within the cells of living organisms. The three main purposes of metabolism are the conversion of food/fuel to energy to run cellular processes, the conversion of food/fuel to building blocks for proteins, lipids, nucleic acids, and some carbohydrates, and the elimination of nitrogenous wastes. These enzyme-catalyzed reactions allow organisms to grow and reproduce, maintain their structures, and respond to their environments. The word metabolism can also refer to the sum of all chemical reactions that occur in living organisms, including digestion and the transport of substances into and between different cells, in which case the set of reactions within the cells is called intermediary metabolism or intermediate metabolism.

Products for Metabolism

  1. Cat.No. Product Name Information
  2. BCN2184 Abiraterone Acotate Abiraterone  Acotate
  3. BCN3479 Alizarin Alizarin
  4. BCN2356 Diosmetin Diosmetin
  5. BCN2180 Ezetimibe Ezetimibe
  6. BCN1060 Lovastatin Potent HMG-CoA reductase inhibitor Lovastatin
  7. BCN2568 Mevastatin HMG-CoA reductase inhibitor Mevastatin
  8. BCN2179 Pemetrexed disodium Pemetrexed disodium
  9. BCN2166 Rasagiline mesylate Selective, irreversible MAO-B inhibitor Rasagiline mesylate
  10. BCN2182 Roflumilast Roflumilast
  11. BCN5412 Rotenone Inhibits complex I of the mitochondrial electron transport chain Rotenone
  12. BCN2569 Simvastatin HMG-CoA reductase inhibitor Simvastatin
  13. BCN2609 Vinpocetine PDE1 inhibitor Vinpocetine
  14. BCC1103 Posaconazole Sterol C14ɑ demethylase inhibitor Posaconazole
  15. BCC1175 17-DMAG (Alvespimycin) HCl Water-soluble Hsp90 inhibitor 17-DMAG (Alvespimycin) HCl
  16. BCC1198 Leucovorin Calcium Derivative of folic acid Leucovorin Calcium
  17. BCC1326 ABT-046 DGAT-1 inhibitor,potent and selective ABT-046
  18. BCC1331 AGI-6780 IDH2/R140Q mutation inhibitor AGI-6780
  19. BCC1337 Aleglitazar PPARα/PPARγagonist Aleglitazar
  20. BCC1361 AN-2728 PDE4 inhibitor,anti-inflammatory compound AN-2728
  21. BCC1394 AZD7687 DGAT inhibitor,potent and selective AZD7687
  22. BCC1395 Balaglitazone PPAR-γ partial agonist Balaglitazone
  23. BCC1405 Bay 60-7550 Potent PDE2 inhibitor Bay 60-7550
  24. BCC1524 Deltarasin KRAS-PDEδ interaction inhibitor Deltarasin
  25. BCC1529 DGAT-1 inhibitor Diacylglycerol acyltransferase (DGAT1) inhibitor DGAT-1 inhibitor
  26. BCC1530 DGAT-1 inhibitor 2 Antiobesity agents DGAT-1 inhibitor 2
  27. BCC1534 DMP 777 Leukocyte elastase (HLE) inhibitor DMP 777
  28. BCC1564 Etomoxir (CPT)-1 and DGAT activity inhibitor Etomoxir
  29. BCC1579 Fluvastatin HMGCR inhibitor Fluvastatin
  30. BCC1605 GSK256066 2,2,2-trifluoroacetic acid PDE4 inhibitor GSK256066 2,2,2-trifluoroacetic acid
  31. BCC1611 GW1929 Potent PPARγ agonist GW1929
  32. BCC1640 IDO inhibitor 1 Indoleamine-2,3-dioxygenase inhibitor IDO inhibitor 1
  33. BCC1647 INCB024360 analogue Potent indoleamine 2,3-dioxygenase (IDO) inhibitor INCB024360 analogue
  34. BCC1652 Inolitazone PPARgamma agonist Inolitazone
  35. BCC1653 Inolitazone dihydrochloride PPARγ agonist,high-affinity and novel Inolitazone dihydrochloride
  36. BCC1687 L-165041 PPARβ/δ agonist,cell permeable,potent and selective L-165041
  37. BCC1692 LCQ-908 DGAT1 inhibitor LCQ-908
  38. BCC1702 Levomefolate calcium Artificial form of folate Levomefolate calcium
  39. BCC1713 LX1606 Tryptophan hydroxylase (TPH) inhibitor LX1606
  40. BCC1714 LX-4211 SGLT1/SGLT2 inhibitor LX-4211
  41. BCC1718 LY2183240 FAAH inhibitor; also inhibits anandamide uptake LY2183240
  42. BCC1769 MK-8245 Trifluoroacetate MK-8245 Trifluoroacetate
  43. BCC1806 Nortadalafil PDE5 inhibitor Nortadalafil
  44. BCC1817 Oglemilast Potent PDE4 inhibitor Oglemilast
  45. BCC1820 Olprinone PDE3 inhibitor Olprinone
  46. BCC1821 Olprinone Hydrochloride Phosphodiesterase 3 (PDE3) inhibitor, selective Olprinone Hydrochloride
  47. BCC1842 PDE-9 inhibitor Useful for neurodegenerative diseases PDE-9 inhibitor
  48. BCC1850 PF-04447943 PDE9 inhibitor PF-04447943
  49. BCC1851 PF-04457845 FAAH inhibitor,potent and exquisitely selective PF-04457845
  50. BCC1852 PF-04971729 SGLT inhibitor PF-04971729
  51. BCC1947 Sildenafil PDE5 inhibitor, selective Sildenafil
  52. BCC2016 Troglitazone Selective PPARγ agonist Troglitazone
  53. BCC2069 Zardaverine PDE3/4 inhibitor Zardaverine
  54. BCC2098 Disulfiram Inhibits expression of MMP-2 and MMP-9; displays a range of other activities Disulfiram
  55. BCC2128 MPC-3100 Hsp90 inhibitor MPC-3100
  56. BCC2131 Radicicol Antifungal antibiotic Radicicol
  57. BCC2259 Abiraterone Potent CYP17 inhibitor Abiraterone
  58. BCC2260 GW9662 PPARγ antagonist GW9662
  59. BCC2261 T0070907 Human PPARγ antagonist,potent and selective T0070907
  60. BCC2262 Rosiglitazone maleate PPARγ agonist,high-affinity and selective,potent insulin sensitizer Rosiglitazone maleate
  61. BCC2263 GSK3787 PPARβ/δ antagonist,novel and irreversible GSK3787
  62. BCC2264 Rosiglitazone Promotes differentiation of adipocytes; also potent and selective PPARγ agonist Rosiglitazone
  63. BCC2265 WY-14643 (Pirinixic Acid) PPARα agonist,selective and highly potent WY-14643 (Pirinixic Acid)
  64. BCC2266 Ciprofibrate Ciprofibrate
  65. BCC2267 GW0742 PPARδ/β agonist,potent and selective GW0742
  66. BCC2268 GW501516 PPARβ agonist,selective and potent GW501516
  67. BCC2269 Rosiglitazone HCl Rosiglitazone HCl
  68. BCC2270 PF-4981517 Selective CYP3A4 inhibitor PF-4981517
  69. BCC2271 Cobicistat (GS-9350) Selective CYP3A inhibitor Cobicistat (GS-9350)
  70. BCC2272 Ketoconazole Cytochrome P450c17 inhibitor Ketoconazole
  71. BCC2273 Apremilast (CC-10004) PDE4 inhibitor Apremilast (CC-10004)
  72. BCC2274 Avasimibe ACAT inhibitor,orally bioavailable Avasimibe
  73. BCC2276 Sildenafil Citrate Orally active, potent PDE5 inhibitor Sildenafil Citrate
  74. BCC2277 Vardenafil HCl Trihydrate PDE5 inhibitor, potent and selective Vardenafil HCl Trihydrate
  75. BCC2278 Pioglitazone HCl PPARγ agonist Pioglitazone HCl
  76. BCC2279 PF-2545920 PDE10A inhibitor,potent and selective PF-2545920
  77. BCC2281 Tadalafil PDE5 inhibitor Tadalafil
  78. BCC2282 Rolipram PDE4 inhibitor Rolipram
  79. BCC2283 Cilomilast Potent PDE4 inhibitor Cilomilast
  80. BCC2284 Isotretinoin Inducer of neuronal differentiation; endogenous agonist for retinoic acid receptors Isotretinoin
  81. BCC2285 GSK256066 PDE4-inhibitor,selective and highly potent GSK256066
  82. BCC2286 Nepicastat (SYN-117) HCl Dopamine-β-hydroxylase inhibitor Nepicastat (SYN-117) HCl
  83. BCC2287 CPI-613 PDH and KGDH inhibitor CPI-613
  84. BCC2289 Mildronate Mildronate
  85. BCC2290 Mycophenolate Mofetil Inosine monophosphate dehydrogenase inhibitor Mycophenolate Mofetil
  86. BCC2291 Cilostazol PDE3A inhibitor. Also adenosine uptake inhibitor Cilostazol
  87. BCC2292 Rivaroxaban Factor Xa inhibitor Rivaroxaban
  88. BCC2293 AGI-5198 IDH1 inhibitor against R132 mutant,selective and cell-permeable AGI-5198
  89. BCC2294 Pimobendan Selective PDE3 inhibitor.Ca2+ channel sensitizer Pimobendan
  90. BCC2296 Gimeracil Dihydropyrimidine dehydrogenase inhibitor Gimeracil
  91. BCC2297 Dyphylline Dyphylline
  92. BCC2298 Ozagrel Thromboxane A2 synthetase inhibitor Ozagrel
  93. BCC2299 MK-8245 SCD inhibitor,potent and liver-selective MK-8245
  94. BCC2300 Aminophylline Aminophylline
  95. BCC2301 Methotrexate Cytotoxic agent Methotrexate
  96. BCC2302 Trilostane Trilostane
  97. BCC2303 S- (+)-Rolipram CAMP-specific PDE4 inhibitor S- (+)-Rolipram
  98. BCC2304 Pralatrexate Antifolate,a folate analog Pralatrexate
  99. BCC2305 PluriSIn #1 (NSC 14613) SCD-1 inhibitor PluriSIn #1 (NSC 14613)
  100. BCC2306 Anagrelide HCl Potent PDE3 inhibitor Anagrelide HCl
  101. BCC2307 Pyrimethamine DHFR inhibitor; also potent inhibitor of multidrug and toxin extrusion (MATE) transporters and STAT3 inhibitor Pyrimethamine

Items 1 to 100 of 259 total

       
  1. 1
  2. 2
  3. 3
  4.  
  5.  
  6. Last